Laboratoire ICARE has sold a minority stake to MBO Partenaires
Naxicap Partners has sold a minority stake in Laboratoire ICARE to MBO Partenaires. Financial details have not been disclosed.
Laboratoire ICARE is the leader in the French market for microbiological analysis in the health industry through sustained growth since its inception in 1995. The company is composed of a multidisciplinary team, highly skilled and distributed in eight support services and two divisions.
Founded in 2002 and wholly owned by its management team, MBO Partenaires is an independent private equity firm with an entrepreneurial mindset. MBO Partenaires has been supporting French SMEs in their growth projects for almost fifteen years, and more recently Spanish, Belgian and Swiss companies as well. With over one hundred transactions completed since its creation, MBO Partenaires has established itself as an involved and committed shareholder alongside the entrepreneurs, making it their leading partner.
Naxicap Partners has been a responsible and committed financial partner for companies for over 30 years, and is now one of the leading providers of equity financing for businesses in France.
Oaklins' team in France advised the seller in this transaction.
Talk to the deal team
Related deals
UKAT Group has acquired Bayberry Limited
UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.
Learn moreMedicija has acquired Saulės Šeimos Medicinos Centras
Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
Learn moreQuimpharma has completed the divestiture of a product portfolio to Megalabs
Quimpharma has completed the divestiture of a product portfolio to Megalabs México.
Learn more